Home › Funds › PFIZER INC › PYXS

PFIZER INC position in PYXS

PYXIS ONCOLOGY INC · Health Care

PFIZER INC reported holding 7,032,770 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$20.1M, representing 12.25% of its reported portfolio and ranking #5 among its reported holdings. PFIZER INC has disclosed PYXS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)7.03M sh
Reported value held$20.11M
Portfolio Weight12.25%
First reportedQ4 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How PFIZER INC's PYXS position evolved

PFIZER INC first disclosed a stake in PYXS in Q4 2024 at 7,032,770 shares (US$11.0M). The position peaked in Q3 2026 at 7,032,770 shares, worth US$20.1M. Across 8 filings, PFIZER INC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 7,032,770 shares valued at US$20.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 7.03M $10.97M New
Q1 2025 7.03M $6.89M Hold
Q2 2025 7.03M $7.74M Hold
Q3 2025 7.03M $15.61M Hold
Q4 2025 7.03M $8.09M Hold
Q1 2026 7.03M $9.21M Hold
Q2 2026 7.03M $19.48M Hold
Q3 2026 7.03M $20.11M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PYXS and 13F data

PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 29 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), Laurion Capital Management LP (US$14.8M), Palo Alto Investors LP (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PYXS

All PYXS fund holders →

FAQ

How long has PFIZER INC held PYXS?

PFIZER INC has disclosed PYXS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is PFIZER INC's current position in PYXS?

As of Q3 2026, PFIZER INC holds 7.03M shares of PYXS (PYXIS ONCOLOGY INC), valued at $20.11M, representing 12.25% of its reported portfolio and ranking #5.

Has PFIZER INC been buying or selling PYXS?

In the latest 13F filing (Q3 2026), PFIZER INC held unchanged its position in PYXS. The position peaked in Q3 2026 at 7.03M shares.

Which other funds hold PYXS?

Other major institutional holders of PYXS include GordonMD Global Investments LP, Laurion Capital Management LP, Palo Alto Investors LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.